Table 2.
CVD complication | B exponential = Odds Ratio(95%CI)* |
All complications | Females;OR = 2.26(1.48–3.47) |
Metabolic syndrome (WHO criteria);OR = 3.48(2.26–5.37) | |
Metabolic syndrome (IDF criteria);OR = 2.28(1.84–4.90) | |
Coronary | Metabolic syndrome (WHO criteria);OR = 3.10(1.48–6.49) |
Metabolic syndrome (IDF criteria);OR = 1.96(1.15–4.89) | |
Cerebrovascular | Females;OR = 2.46(1.06–5.37) |
Metabolic syndrome (NCEP criteria);OR = 2.59(1.26–5.27) | |
Peripheral vascular | Females; OR = 3.61(1.72–7.55) |
Metabolic syndrome (WHO criteria);OR = 2.26(1.11–4.61) | |
Metabolic syndrome (NCEP criteria);OR = 2.74(1.82–5.33) | |
Retinopathy | Metabolic syndrome (NCEP criteria);OR = 2.80(1.07–7.34) |
Metabolic syndrome (IDF criteria);OR = 3.63(2.27–7.94) | |
Nephropathy | Females; OR = 2.97(1.32–6.66) |
Metabolic syndrome (WHO criteria); OR = 11.78(4.91–28.3) | |
Metabolic syndrome (IDF criteria);OR = 3.51(2.07–12.2) | |
Neuropathy | Metabolic syndrome (NCEP criteria);OR = 12.41(1.44–106.9) |
* For each component are indicated those components included in the regression equation. The rest of the components did not reach statistical significance and, as such, have not been included in the table